BGF-backed ROI expands its reach across the Nordic region
BGF-backed lead generation technology company, ROI Media, has acquired Copenhagen-headquartered Unifinance to further increase market share in the financial services digital marketing sector.
The deal will see ROI’s annual revenues boosted by £2 million and EBITDA enhanced by nearly £1 million, as well as providing a significant platform for future growth. Unifinance has established itself as a leading expert in online financial products, developing platforms and accelerating user acquisition.
The transaction marks ROI’s fourth acquisition since BGF backed the business in 2020. This is a strategic acquisition that expands the business’ reach into the financial services sector and has grown its geographical footprint further into Denmark.
Today’s announcement follows just 12 months after the company acquired Copenhagen-based Firstborn Capital, a company providing digital marketing and lead generation in the fintech space.
Robin Kaneteg, co-founder and CEO of ROI said: “Our ambition is to be the number one lead generation company in the Nordic region and UK. With BGF’s support, our strategy is to identify and acquire quality, profitable businesses in our target sectors and locations. Unifinance is a fantastic addition to our business as we continue to build a market-leading reputation in financial services across the Nordic region.”
ROI was founded by Robin Kaneteg and Joel Halling as an innovative lead generation business, which allows small businesses to rent a highly optimised website to attract leads and grow sales. ROI’s proposition is scaleable across different geographies and sectors and the company is quickly building a strong foothold in financial products and services. The company has raised a total of £7 million of growth capital funding from BGF to date.
Business funding news
BGF expands origination team in London and the South East
BGF has strengthened the London team with the appointment of Dylan Kaye in the Origination function. Dylan joins BGF from…
Aberdeen-based Elasmogen receives £8m funding
Elasmogen – a biopharmaceutical company discovering and developing new therapeutics using its unique soloMERTM platform – has secured £8 million…